Celularity Inc. Resolves Nasdaq Compliance Issue, Continues Trading on Nasdaq Stock Market
Celularity Inc. resolved its Nasdaq compliance issue, ensuring continued listing after curing filing delinquencies.Quiver AI SummaryCelularity Inc. announced that its hearing regarding non-compliance with...
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celularity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
CELULARITY ANNOUNCES $45 MILLION PURCHASE ORDER, FIRST MIDDLE EAST PRIVATE LABEL AGREEMENT FOR CELULARITY'S HALAL-CERTIFIED BIOMATERIAL PRODUCTS
/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial...
Celularity Announces Agreement with AD Ports Group for Exclusive Product Distribution in Various Territories in the GCC and Egypt
/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a biotechnology company developing placental-derived allogenic cell therapies and biomaterial...